PROLIA® IS 100% COVERED THROUGH
MEDICARE PART B†
Be sure to ask your doctor how you can get Prolia® through your Part B or Part D benefits
PROLIA® IS ALSO 97% COVERED THROUGH
MEDICARE PART D†
There are independent co-pay foundations that may be able to provide financial assistance for your medicine.‡
†Medicare Part B: Data as of February 2016. Medicare Part D: For the treatment in postmenopausal women with osteoporosis at high risk for fracture. Prescription drug plans covering 97% of Part D beneficiaries include Prolia® on their formularies. Policies for the remaining 3% of beneficiaries were not reviewed. Data do not include costs related to office visits or administration of Prolia®. Individual out-of-pocket costs will vary.
‡Provided through independent nonprofit patient assistance programs; program eligibility is based on the nonprofit’s criteria. Amgen has no control over these programs and provides referrals as a courtesy only.
Pay $25 or less with the Prolia® Co-pay Program†
Amgen offers the Prolia® Co-pay Program to eligible people who have commercial insurance. Read below to learn more about your options.
Prolia® Co-pay Program
(for eligible† commercially insured patients)
†See eligibility and limits.
Close eligibility and limits.
Eligibility Criteria: Open to patients with a Prolia® prescription and commercial insurance for Prolia®. Patients may not seek reimbursement for value received from the Prolia® Co-pay Program from any third-party payers, including a flexible spending account or healthcare savings account. This program is not open to uninsured patients or patients receiving prescription reimbursement under any federal, state, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE, or where prohibited by law. If at any time patients begin receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patients will no longer be able to use this card and you must call the Prolia® Co-pay Program at 844-369-9962 (8:00 am-8:00 pm EST, Monday-Friday) to stop participation. Restrictions may apply. Offer subject to change or discontinuation without notice. This is not health insurance.
Program Details: The Prolia® Co-pay Program is a coupon program that provides financial support for eligible commercially insured patients. For eligible patients, program covers the amount of OOP cost for Prolia® that exceeds $25, up to a maximum benefit of $1,500 per patient, per 12-month enrollment period. Patient is responsible for costs above this amount. The program does not provide support for supplies, procedures, or any physician-related services associated with Prolia®.
For more information about this program and eligibility requirements, call 844-369-9962 or visit .
‡This program does not provide support for any physician-related services associated with administration of Prolia®.
The Prolia® Co-pay Program Prepaid MasterCard® is issued by Comerica Bank pursuant to license by MasterCard International Incorporated. No cash or ATM access. MasterCard is a registered trademark of MasterCard International Incorporated. This card can be used only to cover co-payment for eligible prescriptions covered under the program at participating merchant locations where Debit MasterCard is accepted.
The Amgen Safety Net Foundation supports uninsured patients and certain underinsured patients who do not have coverage for their Amgen medication and have a financial need. Qualifying uninsured patients must not be eligible for Medicaid, Medicare, or any other financial support options. The Amgen Safety Net Foundation may be able to provide Prolia® at no cost to eligible patients.
What are the possible side effects of Prolia®?
It is not known if the use of Prolia® over a long period of time may cause slow healing of broken bones. The most common side effects of Prolia® in women being treated for osteoporosis after menopause are back pain, pain in your arms and legs, high cholesterol, muscle pain, and bladder infection.
The most common side effects of Prolia® in men with osteoporosis are back pain, joint pain, and common cold (runny nose or sore throat).
The most common side effects of Prolia® in patients with corticosteroid-induced osteoporosis are back pain, high blood pressure, lung infection (bronchitis), and headache.
The most common side effects of Prolia® in patients receiving certain treatments for prostate or breast cancer are joint pain, back pain, pain in your arms and legs, and muscle pain. Additionally, in Prolia®-treated men with nonmetastatic prostate cancer receiving ADT, a greater incidence of cataracts was observed.
These are not all the possible side effects of Prolia®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Prolia® is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well.
Prolia® is a prescription medicine used to increase bone mass in men with osteoporosis who are at high risk for fracture.
Prolia® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture.
Prolia® is a prescription medicine used to treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body.
Prolia® is a prescription medicine used to treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body.